BYAH
Income statement / Annual
Last year (2025), Park Ha Biological Technology Co Ltd's total revenue was $2.52 M,
an increase of 6.00% from the previous year.
In 2025, Park Ha Biological Technology Co Ltd's net income was -$24.36 M.
See Park Ha Biological Technology Co Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
10/31/2025 |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
| Operating Revenue |
$2.52 M |
$2.38 M |
$2.46 M |
$1.92 M |
$931.04 K |
| Cost of Revenue |
$142.53 K
|
$195.34 K
|
$310.99 K
|
$509.16 K
|
$311.16 K
|
| Gross Profit |
$2.38 M
|
$2.19 M
|
$2.15 M
|
$1.41 M
|
$619.87 K
|
| Gross Profit Ratio |
0.94
|
0.92
|
0.87
|
0.73
|
0.67
|
| Research and Development Expenses |
$238.18 K
|
$36.71 K
|
$30.88 K
|
$60.67 K
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$814.86 K
|
$484.96 K
|
$707.49 K
|
$751.82 K
|
| Selling & Marketing Expenses |
$0.00
|
$361.33 K
|
$299.62 K
|
$438.60 K
|
$369.03 K
|
| Selling, General & Administrative Expenses |
$26.29 M
|
$1.18 M
|
$784.57 K
|
$1.15 M
|
$1.12 M
|
| Other Expenses |
$0.00
|
$179.90 K
|
$152.11 K
|
$6.44 K
|
$0.00
|
| Operating Expenses |
$26.53 M
|
$1.39 M
|
$967.56 K
|
$1.21 M
|
$1.12 M
|
| Cost And Expenses |
$26.67 M
|
$1.59 M
|
$1.28 M
|
$1.72 M
|
$1.43 M
|
| Interest Income |
$6.10 K
|
$783.00
|
$1.59 K
|
$263.00
|
$167.00
|
| Interest Expense |
$41.00
|
$0.00
|
$0.00
|
$194.00
|
$1.19 K
|
| Depreciation & Amortization |
$109.37 K
|
$22.69 K
|
$20.06 K
|
$30.49 K
|
$39.01 K
|
| EBITDA |
-$24.04 M |
$816.40 K |
$1.20 M |
$220.70 K |
-$444.76 K |
| EBITDA Ratio |
-9.52
|
0.34
|
0.49
|
0.11
|
-0.48
|
| Operating Income Ratio |
-9.56
|
0.33
|
0.48
|
0.1
|
-0.54
|
| Total Other Income/Expenses Net |
$64.79 K
|
-$293.00
|
$1.02 K
|
-$7.01 K
|
$16.02 K
|
| Income Before Tax |
-$24.08 M
|
$793.42 K
|
$1.18 M
|
$190.01 K
|
-$484.96 K
|
| Income Before Tax Ratio |
-9.54
|
0.33
|
0.48
|
0.1
|
-0.52
|
| Income Tax Expense |
$280.65 K
|
$314.86 K
|
$329.53 K
|
-$1.29 K
|
$0.00
|
| Net Income |
-$24.36 M
|
$478.56 K
|
$852.04 K
|
$191.30 K
|
-$484.96 K
|
| Net Income Ratio |
-9.65
|
0.2
|
0.35
|
0.1
|
-0.52
|
| EPS |
-41.38 |
0.915 |
1.625 |
0.365 |
-0.925 |
| EPS Diluted |
-41.38 |
0.915 |
1.625 |
0.365 |
-0.925 |
| Weighted Average Shares Out |
$588.87 K
|
$524.00 K
|
$524.00 K
|
$524.00 K
|
$524.00 K
|
| Weighted Average Shares Out Diluted |
$588.87 K
|
$524.00 K
|
$524.00 K
|
$524.00 K
|
$524.00 K
|
| Link |
|
|
|
|
|
